U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 2280

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr10:43620311-43623717
RETMultiple endocrine neoplasia, type 2Uncertain significance
(Mar 1, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr10:43606692
GRCh38:
Chr10:43111244
RETS259N, S288N, S302N, S338N, S391N, S434N, S104N, S180N, S192NMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 18, 2022)
criteria provided, single submitter
3.
GRCh37:
Chr10:43604483
GRCh38:
Chr10:43109035
RETMultiple endocrine neoplasia, type 2Likely benign
(Jan 6, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr10:43604470
GRCh38:
Chr10:43109022
RETMultiple endocrine neoplasia, type 2Likely benign
(Oct 24, 2022)
criteria provided, single submitter
5.
GRCh37:
Chr10:43610191
GRCh38:
Chr10:43114743
RETMultiple endocrine neoplasia, type 2Likely benign
(Jan 18, 2022)
criteria provided, single submitter
6.
GRCh37:
Chr10:43597935
GRCh38:
Chr10:43102487
RETK118N, K161NMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 23, 2022)
criteria provided, single submitter
7.
GRCh37:
Chr10:43623684
GRCh38:
Chr10:43128236
RETMultiple endocrine neoplasia, type 2Likely benign
(Feb 27, 2022)
criteria provided, single submitter
8.
GRCh37:
Chr10:43597827
GRCh38:
Chr10:43102379
RETMultiple endocrine neoplasia, type 2Likely benign
(Sep 17, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr10:43622013
GRCh38:
Chr10:43126565
RETMultiple endocrine neoplasia, type 2Likely benign
(Jun 29, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr10:43601809
GRCh38:
Chr10:43106361
RETMultiple endocrine neoplasia, type 2Likely benign
(Apr 21, 2022)
criteria provided, single submitter
11.
GRCh37:
Chr10:43623697
GRCh38:
Chr10:43128249
RETM1013V, M1064V, M1089V, M963V, M1109V, M626V, M714V, M810V, M847V, M1066V, M606V, M767V, M867V, M977VMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 8, 2022)
criteria provided, single submitter
12.
GRCh37:
Chr10:43601804
GRCh38:
Chr10:43106356
RETMultiple endocrine neoplasia, type 2Likely benign
(Jul 22, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr10:43600382
GRCh38:
Chr10:43104934
RETMultiple endocrine neoplasia, type 2Likely benign
(Dec 22, 2021)
criteria provided, single submitter
14.
GRCh37:
Chr10:43600497
GRCh38:
Chr10:43105049
RETMultiple endocrine neoplasia, type 2Likely benign
(Jul 6, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr10:43607650
GRCh38:
Chr10:43112202
RETMultiple endocrine neoplasia, type 2Likely benign
(Mar 12, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr10:43604630
GRCh38:
Chr10:43109182
RETMultiple endocrine neoplasia, type 2Likely benign
(May 21, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr10:43608385
GRCh38:
Chr10:43112937
RETI236T, I336T, I432T, I482T, I535T, I578T, I183T, I279T, I324T, I95T, I248T, I403T, I446TMultiple endocrine neoplasia, type 2Uncertain significance
(Feb 28, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr10:43600381-43600382
GRCh38:
Chr10:43104933-43104934
RETMultiple endocrine neoplasia, type 2Likely benign
(Sep 20, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr10:43609004-43609005
GRCh38:
Chr10:43113556-43113557
RETR104Q, R288Q, R192Q, R245Q, R257Q, R412Q, R441Q, R455Q, R587Q, R333Q, R345Q, R491Q, R544QMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 21, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr10:43597938
GRCh38:
Chr10:43102490
RETMultiple endocrine neoplasia, type 2Likely benign
(Dec 14, 2021)
criteria provided, single submitter
21.
GRCh37:
Chr10:43614959
GRCh38:
Chr10:43119511
RETMultiple endocrine neoplasia, type 2Benign
(Jan 27, 2022)
criteria provided, single submitter
22.
GRCh37:
Chr10:43610013
GRCh38:
Chr10:43114565
RETF260L, F413L, F480L, F559L, F509L, F523L, F316L, F612L, F172L, F220L, F313L, F325L, F356L, F401L, F655LMultiple endocrine neoplasia, type 2Uncertain significance
(Dec 18, 2021)
criteria provided, single submitter
23.
GRCh37:
Chr10:43620325
GRCh38:
Chr10:43124877
RETMultiple endocrine neoplasia, type 2Likely benign
(Jan 2, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr10:43622099
GRCh38:
Chr10:43126651
RETP695R, P556R, P709R, P785R, P943R, P951R, P996R, P1039R, P700R, P740R, P797R, P864R, P893R, P907R, P604R, P644R, P697R, P994RMultiple endocrine neoplasia, type 2Uncertain significance
(Oct 3, 2022)
criteria provided, single submitter
25.
GRCh37:
Chr10:43604557
GRCh38:
Chr10:43109109
RETF127C, F139C, F381C, F338C, F235C, F285C, F51CMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 15, 2022)
criteria provided, single submitter
26.
GRCh37:
Chr10:43600661
GRCh38:
Chr10:43105213
RETMultiple endocrine neoplasia, type 2Likely benign
(Jun 13, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr10:43607541
GRCh38:
Chr10:43112093
RETMultiple endocrine neoplasia, type 2Likely benign
(Mar 19, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr10:43604491
GRCh38:
Chr10:43109043
RETN105S, N29S, N359S, N117S, N263S, N316S, N213SMultiple endocrine neoplasia, type 2Uncertain significance
(Jun 30, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr10:43619183
GRCh38:
Chr10:43123735
RETP521S, P617S, P824S, P956S, P473S, P612S, P626S, P657S, P781S, P868S, P911S, P561S, P614S, P702S, P714S, P810S, P860S, P913SMultiple endocrine neoplasia, type 2Uncertain significance
(Jun 4, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr10:43601866
GRCh38:
Chr10:43106418
RETV261I, V208I, V304I, V50IMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 26, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr10:43615515
GRCh38:
Chr10:43120067
RETMultiple endocrine neoplasia, type 2Likely benign
(Aug 16, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr10:43596176
GRCh38:
Chr10:43100728
RETMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 22, 2022)
criteria provided, single submitter
33.
GRCh37:
Chr10:43606676
GRCh38:
Chr10:43111228
RETN254D, N333D, N187D, N297D, N175D, N386D, N99D, N283D, N429DMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 24, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr10:43623544
GRCh38:
Chr10:43128096
RETMultiple endocrine neoplasia, type 2Likely benign
(Oct 30, 2022)
criteria provided, single submitter
35.
GRCh37:
Chr10:43598068
GRCh38:
Chr10:43102620
RETL206F, L163FMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 18, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr10:43609078
GRCh38:
Chr10:43113630
RETF313L, F437L, F569L, F282L, F358L, F129L, F466L, F612L, F217L, F270L, F370L, F480L, F516LMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 1, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr10:43610046
GRCh38:
Chr10:43114598
RETMultiple endocrine neoplasia, type 2Likely benign
(Sep 24, 2021)
criteria provided, single submitter
38.
GRCh37:
Chr10:43610201
GRCh38:
Chr10:43114753
RETMultiple endocrine neoplasia, type 2Likely benign
(Sep 26, 2022)
criteria provided, single submitter
39.
GRCh37:
Chr10:43615119
GRCh38:
Chr10:43119671
RETA501S, A603S, A699S, A713S, A749S, A845S, A362S, A515S, A670S, A757S, A450S, A503S, A591S, A800S, A802S, A410S, A506S, A546SMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 20, 2022)
criteria provided, single submitter
40.
GRCh37:
Chr10:43610198
GRCh38:
Chr10:43114750
RETMultiple endocrine neoplasia, type 2Likely benign
(May 12, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr10:43597786
GRCh38:
Chr10:43102338
RETMultiple endocrine neoplasia, type 2Likely benign
(Aug 24, 2022)
criteria provided, single submitter
42.
GRCh37:
Chr10:43604544
GRCh38:
Chr10:43109096
RETN281D, N135D, N231D, N123D, N334D, N377D, N47DMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 6, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr10:43604480
GRCh38:
Chr10:43109032
RETR101S, R259S, R355S, R113S, R312SMultiple endocrine neoplasia, type 2Uncertain significance
(Feb 22, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr10:43601807
GRCh38:
Chr10:43106359
RETMultiple endocrine neoplasia, type 2Likely benign
(Apr 29, 2022)
criteria provided, single submitter
45.
GRCh37:
Chr10:43622186
GRCh38:
Chr10:43126738
RETA922V, A972V, A1025V, A729V, A814V, A893V, A1068V, A585V, A633V, A673V, A769V, A980V, A1023V, A724V, A726V, A738V, A826V, A936VMultiple endocrine neoplasia, type 2Likely benign
(Aug 2, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr10:43609105
GRCh38:
Chr10:43113657
RETE291K, E367K, E379K, E446K, E525K, E578K, E322K, E138K, E226K, E279K, E475K, E489K, E621KMultiple endocrine neoplasia, type 2Uncertain significance
(Feb 19, 2022)
criteria provided, single submitter
47.
GRCh37:
Chr10:43609911
GRCh38:
Chr10:43114463
RETMultiple endocrine neoplasia, type 2Likely benign
(Sep 25, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr10:43617483
GRCh38:
Chr10:43122035
RETMultiple endocrine neoplasia, type 2Likely benign
(Sep 16, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr10:43595986
GRCh38:
Chr10:43100538
RETMultiple endocrine neoplasia, type 2Likely benign
(Oct 12, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr10:43598007
GRCh38:
Chr10:43102559
RETF185L, F142LMultiple endocrine neoplasia, type 2Uncertain significance
(Jun 1, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr10:43607656
GRCh38:
Chr10:43112208
RETMultiple endocrine neoplasia, type 2Likely benign
(Aug 31, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr10:43606754
GRCh38:
Chr10:43111306
RETV323F, V412F, V125F, V201F, V213F, V359F, V455F, V280F, V309FMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 11, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr10:43622101
GRCh38:
Chr10:43126653
RETMultiple endocrine neoplasia, type 2Likely benign
(Dec 24, 2021)
criteria provided, single submitter
54.
GRCh37:
Chr10:43604497
GRCh38:
Chr10:43109049
RETN318I, N107I, N119I, N215I, N361I, N265I, N31IMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 1, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr10:43596112
GRCh38:
Chr10:43100664
RETMultiple endocrine neoplasia, type 2Likely benign
(Aug 19, 2022)
criteria provided, single submitter
56.
GRCh37:
Chr10:43597777
GRCh38:
Chr10:43102329
RETMultiple endocrine neoplasia, type 2Likely benign
(Jan 10, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr10:43608985
GRCh38:
Chr10:43113537
RETMultiple endocrine neoplasia, type 2Likely benign
(Oct 12, 2022)
criteria provided, single submitter
58.
GRCh37:
Chr10:43606844
GRCh38:
Chr10:43111396
RETV155L, V310L, V339L, V231L, V389L, V442L, V485L, V353L, V243LMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 3, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr10:43615120
GRCh38:
Chr10:43119672
RETA362V, A591V, A749V, A800V, A501V, A503V, A699V, A757V, A802V, A515V, A546V, A603V, A410V, A450V, A506V, A670V, A713V, A845VMultiple endocrine neoplasia, type 2Uncertain significance
(Oct 9, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr10:43597998
GRCh38:
Chr10:43102550
RETMultiple endocrine neoplasia, type 2Likely benign
(Jul 5, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr10:43622020
GRCh38:
Chr10:43126572
RETMultiple endocrine neoplasia, type 2Uncertain significance
(Oct 27, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr10:43597937
GRCh38:
Chr10:43102489
RETP162R, P119RMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 27, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr10:43609076-43609077
GRCh38:
Chr10:43113628-43113629
RETC611Y, C357Y, C216Y, C281Y, C515Y, C128Y, C269Y, C479Y, C568Y, C312Y, C369Y, C436Y, C465YMultiple endocrine neoplasia, type 2Pathogenic
(Apr 12, 2022)
criteria provided, single submitter
64.
GRCh37:
Chr10:43604493
GRCh38:
Chr10:43109045
RETR106W, R30W, R118W, R264W, R360W, R214W, R317WMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 2, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr10:43597812
GRCh38:
Chr10:43102364
RETMultiple endocrine neoplasia, type 2Likely benign
(Oct 13, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr10:43606882
GRCh38:
Chr10:43111434
RETQ351H, Q243H, Q322H, Q365H, Q255H, Q401H, Q167H, Q454H, Q497HMultiple endocrine neoplasia, type 2Uncertain significance
(May 9, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr10:43601871
GRCh38:
Chr10:43106423
RETMultiple endocrine neoplasia, type 2Likely benign
(May 7, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr10:43614987
GRCh38:
Chr10:43119539
RETL462F, L626F, L756F, L406F, L471F, L547F, L559F, L669F, L366F, L713F, L801F, L318F, L457F, L459F, L502F, L655F, L705F, L758FMultiple endocrine neoplasia, type 2Uncertain significance
(May 7, 2022)
criteria provided, single submitter
69.
GRCh37:
Chr10:43607646
GRCh38:
Chr10:43112198
RETC498Y, C211Y, C242Y, C395Y, C409Y, C199Y, C287Y, C445Y, C58Y, C146Y, C299Y, C366Y, C541YMultiple endocrine neoplasia, type 2Likely pathogenic
(May 20, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr10:43597847
GRCh38:
Chr10:43102399
RETL132RMultiple endocrine neoplasia, type 2Uncertain significance
(May 4, 2022)
criteria provided, single submitter
71.
GRCh37:
Chr10:43619104
GRCh38:
Chr10:43123656
RETMultiple endocrine neoplasia, type 2Likely benign
(Jun 3, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr10:43606854
GRCh38:
Chr10:43111406
RETT392N, T488N, T234N, T313N, T342N, T445N, T158N, T246N, T356NMultiple endocrine neoplasia, type 2Uncertain significance
(Dec 2, 2021)
criteria provided, single submitter
73.
GRCh37:
Chr10:43620322
GRCh38:
Chr10:43124874
RETMultiple endocrine neoplasia, type 2Likely benign
(May 3, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr10:43601846
GRCh38:
Chr10:43106398
RETR254P, R297P, R201P, R43PMultiple endocrine neoplasia, type 2Uncertain significance
(May 22, 2022)
criteria provided, single submitter
75.
GRCh37:
Chr10:43604562
GRCh38:
Chr10:43109114
RETG53S, G237S, G287S, G340S, G129S, G141S, G383SMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 28, 2022)
criteria provided, single submitter
76.
GRCh37:
Chr10:43604531
GRCh38:
Chr10:43109083
RETMultiple endocrine neoplasia, type 2Likely benign
(Apr 28, 2022)
criteria provided, single submitter
77.
GRCh37:
Chr10:43601970
GRCh38:
Chr10:43106522
RETMultiple endocrine neoplasia, type 2Likely benign
(Apr 28, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr10:43596111
GRCh38:
Chr10:43100663
RETG93DMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 28, 2022)
criteria provided, single submitter
79.
GRCh37:
Chr10:43600567
GRCh38:
Chr10:43105119
RETE222K, E265K, E11K, E169KMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 20, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr10:43601845
GRCh38:
Chr10:43106397
RETR254S, R297S, R201S, R43SMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 18, 2022)
criteria provided, single submitter
81.
GRCh37:
Chr10:43596085
GRCh38:
Chr10:43100637
RETMultiple endocrine neoplasia, type 2Likely benign
(Apr 11, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr10:43620421
GRCh38:
Chr10:43124973
RETMultiple endocrine neoplasia, type 2Likely benign
(Apr 11, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr10:43601997-43601998
GRCh38:
Chr10:43106549-43106550
RETV351fs, V97fsMultiple endocrine neoplasia, type 2Pathogenic
(Jun 9, 2022)
criteria provided, single submitter
84.
GRCh37:
Chr10:43609941
GRCh38:
Chr10:43114493
RETD289E, D377E, D535E, D148E, D292E, D456E, D631E, D236E, D301E, D485E, D499E, D196E, D332E, D389E, D588EMultiple endocrine neoplasia, type 2Uncertain significance
(May 9, 2022)
criteria provided, single submitter
85.
GRCh37:
Chr10:43601930
GRCh38:
Chr10:43106482
RETA71V, A325V, A229V, A282VMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 10, 2022)
criteria provided, single submitter
86.
GRCh37:
Chr10:43609973-43609975
GRCh38:
Chr10:43114525-43114527
RETL208del, L389del, L600del, L160del, L468del, L248del, L301del, L304del, L344del, L401del, L547del, L313del, L497del, L511del, L643delMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 6, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr10:43615667
GRCh38:
Chr10:43120219
RETMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 22, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr10:43613854
GRCh38:
Chr10:43118406
RETL434R, L677R, L685R, L290R, L338R, L378R, L429R, L730R, L773R, L443R, L474R, L627R, L641R, L728R, L431R, L519R, L531R, L598RMultiple endocrine neoplasia, type 2Uncertain significance
(Mar 31, 2022)
criteria provided, single submitter
89.
GRCh37:
Chr10:43619189
GRCh38:
Chr10:43123741
RETE619Q, E628Q, E704Q, E870Q, E913Q, E523Q, E812Q, E862Q, E958Q, E475Q, E563Q, E616Q, E716Q, E783Q, E826Q, E614Q, E659Q, E915QMultiple endocrine neoplasia, type 2Uncertain significance
(Mar 29, 2022)
criteria provided, single submitter
90.
GRCh37:
Chr10:43606872
GRCh38:
Chr10:43111424
RETR252K, R348K, R319K, R451K, R494K, R164K, R240K, R362K, R398KMultiple endocrine neoplasia, type 2Uncertain significance
(Jun 9, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr10:43600649
GRCh38:
Chr10:43105201
RETMultiple endocrine neoplasia, type 2Likely benign
(Mar 26, 2022)
criteria provided, single submitter
92.
GRCh37:
Chr10:43601983
GRCh38:
Chr10:43106535
RETN300H, N89H, N247H, N343HMultiple endocrine neoplasia, type 2Uncertain significance
(Mar 19, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr10:43597976
GRCh38:
Chr10:43102528
RETR132L, R175LMultiple endocrine neoplasia, type 2Uncertain significance
(Mar 18, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr10:43609980
GRCh38:
Chr10:43114532
RETMultiple endocrine neoplasia, type 2Likely benign
(Mar 14, 2022)
criteria provided, single submitter
95.
GRCh37:
Chr10:43610178
GRCh38:
Chr10:43114730
RETMultiple endocrine neoplasia, type 2Likely benign
(Mar 14, 2022)
criteria provided, single submitter
96.
GRCh37:
Chr10:43617387
GRCh38:
Chr10:43121939
RETMultiple endocrine neoplasia, type 2Likely benign
(May 4, 2022)
criteria provided, single submitter
97.
GRCh37:
Chr10:43620380
GRCh38:
Chr10:43124932
RETV562L, V698L, V997L, V514L, V655L, V667L, V743L, V851L, V909L, V653L, V755L, V901L, V602L, V658L, V822L, V865L, V952L, V954LMultiple endocrine neoplasia, type 2Uncertain significance
(Jun 19, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr10:43622031
GRCh38:
Chr10:43126583
RETL686F, L717F, L762F, L774F, L920F, L581F, L672F, L677F, L971F, L533F, L870F, L928F, L1016F, L621F, L674F, L841F, L884F, L973FMultiple endocrine neoplasia, type 2Uncertain significance
(Mar 16, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr10:43572762
GRCh38:
Chr10:43077314
RETL19PHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Dec 18, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr10:43615105
GRCh38:
Chr10:43119657
RETH501L, H510L, H708L, H744L, H795L, H498L, H541L, H586L, H797L, H840L, H357L, H405L, H445L, H665L, H694L, H496L, H598L, H752LMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 7, 2022)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination